3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Breast Neoplasms
33
Neoplasms
25
Prostatic Neoplasms
16
Colorectal Neoplasms
13
Lung Neoplasms
11
Multiple Myeloma
9
Head and Neck Neoplasms
8
Carcinoma, Non-Small-Cell Lung
8
Pancreatic Neoplasms
6
Neoplasm Metastasis
6
Urinary Bladder Neoplasms
5
Hematologic Neoplasms
5
Gastrointestinal Neoplasms
5
Advanced Cancer
5
Uterine Cervical Neoplasms
4
Smoking Cessation
4
Ovarian Neoplasms
4
Melanoma
4
Leukemia
4
Colonic Neoplasms
4
Anxiety Disorders
4
Triple Negative Breast Neoplasms
3
Stomach Neoplasms
3
Small Cell Lung Carcinoma
3
Recurrence
3
Rectal Neoplasms
3
Neoplasms, Plasma Cell
3
Motor Activity
3
Lymphoma, Follicular
3
Lymphedema
3
Interventions
Temozolomide
7
Carboplatin
4
Vincristine
3
Surveys and Questionnaires
3
Radiotherapy
3
Magnetic Resonance Imaging
3
Bevacizumab
3
Vorinostat
2
Magnetic Resonance Spectroscopy
2
Immunoglobulin G
2
Fluorodeoxyglucose F18
2
Etoposide
2
Disulfides
2
veliparib
1
tozuleristide
1
romidepsin
1
lonafarnib
1
ispinesib
1
etoposide phosphate
1
emvododstat
1
cediranib
1
Valproic Acid
1
Thiotepa
1
Standard of Care
1
Saline Solution
1
Radiosurgery
1
Radiation
1
Pregabalin
1
Peripheral Blood Stem Cell Transplantation
1
Nivolumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Spinal Cord Neoplasms
×
Standard of Care
×
Clear all
NCT03050203
2019-01-28
kit
Istituto Ortopedico Rizzoli
Phase NA
Completed
37 enrolled
5 charts